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Background: Fluorescently labeled ligands and flow cy-
tometric methods allow quantification of receptor-ligand
binding. Such methods require calibration of the fluores-
cence of bound ligands. Moreover, binding of unlabeled
ligands can be calculated based on their abilities to com-
pete with a labeled ligand. In this study, calibration pa-
rameters were determined for six fluorescently labeled
N-formyl peptides that bind to receptors on neutrophils.
Two of these ligands were then used to develop and
validate competitive binding protocols for determining
binding constants of unlabeled ligands.
Methods: Spectrofluorometric and flow cytometric
methods for converting relative flow cytometric inten-
sities to number of bound ligand/cell were extended to
include peptides labeled with fluorescein, Bodipy, and
tetramethylrhodamine. The validity of flow cytometric
competitive binding protocols was tested using two
ligands with different fluorescent properties that al-
lowed determination of rate constants both directly and
competitively for one ligand, CHO-NLFNYK-tetrameth-
ylrhodamine.
Results: Calibration parameters were determined for six
fluorescently-labeled N-formyl peptides. Equilibrium disso-
ciation constants for these ligands varied over two orders
of magnitude and depended upon the peptide sequence
and the molecular structure of the fluorescent tag. Kinetic
rate constants for CHO-NLFNYK-tetramethylrhodamine
determined directly or in competition with CHO-
NLFNYK-fluorescein were statistically identical.
Conclusions: Combination of spectrofluorometric and
flow cytometric methods allows convenient calculation of
calibration parameters for a series of fluorescent ligands
that bind to the same receptor site. Competitive binding
protocols have been independently validated. Cytometry
45:102–114, 2001. © 2001 Wiley-Liss, Inc.
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The relationship between receptor-ligand binding and
processing and cellular responses may be elucidated, at
least in part, by determining values of the rate constants
for receptor/ligand binding and processing (1,2,3). One
can ask, for example, whether the initial rate of ligand
binding correlates with the timing of the cellular re-
sponse, or if there are other rate-limiting steps involved.
Are the rates of receptor desensitization ligand-depen-
dent, and does this contribute to differences in ligand
efficacy? The answers to these and related questions re-
quire a quantitative method for obtaining rate constants
for receptor-ligand binding and processing with a variety
of ligands.
Receptor-ligand binding can be monitored by spec-
trofluorometry or flow cytometry when a fluorescently
labeled ligand is available. Compared to radioligand meth-
ods, flow cytometry offers the advantage of monitoring
ligand binding to single cells in real time without the need
to separate bound from unbound ligands. These binding
data can be collected on a microsecond time scale and,
because single-cell fluorescence is measured, the hetero-
geneity in the binding properties of the population of cells
can be detected. The background fluorescence of the
unbound ligands is minimized by the small volume probed
by the flow cytometric laser, on the order of the volume
of a single cell.
However, this is only the case for high-affinity ligands.
For a low-affinity ligand (i.e., large equilibrium dissocia-
tion constant, Kd), a higher ligand concentration is re-
quired to reach the same number of bound receptors as a
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high-affinity ligand, thus there is more free ligand present
in the media. This free ligand contributes to the apparent
background fluorescence and can lead to the inability to
distinguish bound versus unbound ligand. Thus competi-
tive protocols have been developed in which binding of
an unlabeled ligand is calculated based on its ability to
influence the binding of a fluorescent ligand. A goal of this
work is to validate these competitive binding protocols.
Because flow cytometry measurements give fluores-
cence on a relative intensity scale, one can only convert
fluorescence readings to numbers of bound ligands if an
appropriate calibration technique is available. Fay et al. (4)
have reported methods for calibrating fluorescein-labeled
ligands to free fluorescein and for evaluating possible
quenching of fluorescein-labeled ligand upon binding
to the receptor. An additional goal of this paper was to
expand upon the calibration methods of Fay et al. (4) to
include ligands labeled with fluorophores other than flu-
orescein. We report calibration values for the fluores-





ine (CHO-NLFNYK-TMR), all of which bind to the N-
formyl peptide receptor on human neutrophils. In





lysine-fluorescein (CHO-NLFNYK-FL). These calibration
methods are applicable to any cell surface receptor system
for which a fluorescently labeled ligand can be obtained,
given the constraints of flow cytometric sensitivity and
ligand affinity as discussed by Murphy (5). We also report
equilibrium binding constants for various N-formyl pep-
tides and estimates of their quenching caused by interac-
tion with the receptor.
We then used two of these ligands to validate the
competitive binding protocols. Flow cytometry requires
the attachment of a fluorescent tag to the ligand, which
could lead to the inability of the ligand to bind with the
receptor or elicit a cellular response. To monitor the
binding of unlabeled ligands, or native ligands, competi-
tive binding methods have been used (6–8). Given infor-
mation on the binding of the fluorescent ligand alone, the
binding of the unlabeled ligand can then be calculated
indirectly from its affect on the binding of labeled ligand.
This approach is attractive because many unlabeled li-
gands are available and they can be used without regard to
Kd because distinction of bound and free unlabeled li-
gands is not an issue. Although competitive binding has
been used to calculate binding rate constants for unla-
beled ligands, this technique has never been indepen-
dently verified.
Utilizing two labeled ligands with different fluorescence
characteristics, we now report the independent validation
of competitive binding protocols for accurately determin-
ing the rate constants for a two site receptor system, the
N-formyl peptide receptor system on the human neutro-
phil.
The N-formyl peptide receptor on the neutrophil is
capable of binding to many short peptide sequences (9–
11), including fluorescently labeled peptides, and elicits
responses that include chemotaxis, oxidant production,
and phagocytosis. Pioneering work by Sklar et al. (12) and
more recently by Hoffman et al. (8) have demonstrated
that the binding of several N-formyl peptides, CHO-
NLFNYK-FL, N-formyl-norleucyl-leucyl-phenylalanyl (CHO-
NLF), and N-formyl-methionyl-leucyl-phenylalanyl (CHO-
MLF), at 4°C can be described by the two site receptor
binding scheme:








L 1 Rx (Model I)
Ligand (L) binds to surface receptors (Rs) with rate con-
stant kf to form low-affinity receptor-ligand complexes
(LRs), which convert to high-affinity complexes (LRx) with
rate constant kx. High-affinity complexes are also formed
by ligand binding to high-affinity state receptors (Rx) with
the rate constant kf2. Ligand can dissociate from low- or
high-affinity receptor-ligand complexes with rate con-
stants kr and kr2, respectively. At 4°C, receptor trafficking
is minimized and the total number of surface receptors,
Rtot, equal to the sum of the receptor states described
above, remains constant. Because the low-affinity recep-
tor/ligand complex is believed to be the receptor state
responsible for signaling (8,13) the rate constants, kf, kr,
and kx, which govern the formation and lifetime of the
low-affinity receptor-ligand complex, may be critical for
determining cellular response characteristics.
The two hexapeptides, CHO-NLFNYK-FL and CHO-
NLFNYK-TMR, were utilized for validating the competi-
tive binding protocol by evaluating independently the
kinetic binding rate constants that describe the interaction
between these ligands and the N-formyl peptide receptor.
These direct measurements were then compared with
values of kinetic binding rate constants evaluated via a
competitive binding protocol in which CHO-NLFNYK-FL
was the “labeled” ligand and CHO-NLFNYK-TMR the “un-
labeled” ligand. The similarity of CHO-NLFNYK-TMR rate
constants determined by direct and competitive protocols
validates the competitive protocols.
MATERIALS AND METHODS
Reagents
Standard cellular and ligand buffer (HSB) contained 5
mM KCl, 147 mM NaCl, 1.9 mM KH2PO4, 0.22 mM
Na2HPO4, 5.5 mM glucose, 0.3 mM MgSO4, 1 mM MgCl2,
and 10 mM HEPES, at pH 7.4. To minimize loss of peptide
ligand caused by nonspecific binding to containers, 1
mg/ml (0.1%) bovine serum albumin was added to HSB.
Bovine serum albumin (BSA), tert-butyloxycarbonyl-phe-
nylalanyl-leucyl-phenylalanyl-leucyl-phenylalanine (t-Boc),
N-formyl-methionyl-leucyl-phenylalanine (CHO-MLF), tri-
ethylamine, and fluorescein were obtained from Sigma-
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Aldrich Chemical Co. (St. Louis, MO). CHO-NLFNYK-FL,
CHO-NLFNYK-Bodipy, and CHO-NLFNYK-TMR were ob-
tained from Molecular Probes, Inc. (Eugene, OR) and
CHO-MLFK-FL from Peninsula Laboratories, Inc. (Belmont,
CA). All ligands were stored in stock solutions of 10-3 M in
dimethylsulfoxide (DMSO; Pierce Chemical Co., Rock-
ford, IL). Other solvents, chloroform, methanol (MeOH),
and acetic acid were obtained from Fisher Scientific (Chi-
cago, IL).
Synthesis and Purification of Fluorescein-Labeled
Pentapeptides
The pentapeptides CHO-MLFFK and CHO-NLFFK were
synthesized by the Peptide Synthesis Facility of the Uni-
versity of Michigan. Each peptide was reacted with fluo-
rescein isothiocyanate (Molecular Probes, Inc., Eugene,
OR) (14,15). The fluorescein-labeled peptides were puri-
fied from the reaction mixture on tapered silica gel plates
(Uniplate-T taper plates from Analtech, Newark, DE) using
chloroform/MeOH/triethylamine (5/3/1) as described by
Sklar (14). The labeled peptide bands were scraped and
eluted in MeOH. Quantification of the recovered material
was achieved by measuring the absorbency at 495 nm of
product in MeOH on a Gilford spectrophotometer using
an extinction coefficient of 8.1 3 104 for FITC labeled
peptide (16). After quantification of the product, the
MeOH was evaporated and the product dissolved in
DMSO and stored at 220°C. Purity of the ligands was
confirmed by HPLC analysis and thin layer chromatogra-
phy. HPLC was performed with a Vydac C-18 column
using a gradient solvent system. Solvent A was 99.9%
water and 0.1% trifluoroacetic acid, and solvent B was
19.9% water, 80% acetonitrile, and 0.1% trifluoroacetic
acid. The gradient of solvent B was run from 0 to 100% in
40 min at 0.7 mL/min. Thin layer chromatography on
silica gel G and GF (2.5 3 7.5 cm plates) was performed
with two solvent systems: chloroform/MeOH/triethyl-
amine (5/3/1; v/v/v) and chloroform/methanol/acetic acid
(3/1/0.01; v/v/v) (14,17).
Neutrophil Isolation
Neutrophils were isolated via the protocol of Tolley et
al. (18) and maintained at 4°C in HSB buffer at 108 cell/ml
until used for experiments (within 2 h of isolation).
Calibration of Fluorescently Labeled Ligand
Spectrofluorometric determination of F. Emis-
sions from solutions of free fluorescein and fluorescently
labeled ligands were measured on a spectrofluorometer
(SLM-Aminco 8100, Urbana, IL) to calculate the quantum
yield ratio F much as described by Fay et al. (4). The ratio
F is the number of free ligands per fluorescein equivalent
(the ratio of the quantum yield of fluorescein to that of
free ligand). The emission wavelength used for the fluo-
rescein- and Bodipy-labeled ligands was 530 nm and for
the tetramethylrhodamine labeled ligand was 580 nm.
These correspond closely to the wavelengths of the flow
cytometer detectors, FL1 and FL2 (see below).
Free fluorescein was dissolved in nanopure water to a
final concentration of 10-3 M and then diluted 1:100 in
HSB/BSA. Further dilutions into spectrofluorometer cu-
vettes (Fisher Scientific, Pittsburgh, PA) using HSB/BSA
were made to give a concentration series with the range
of 0.25 3 1026 M to 1.50 3 10-6 M. The fluorescein
concentrations were verified by absorbance measure-
ments at 495 nm with the reported extinction coefficient
of 7.25 3 104 (19).
Stock solutions of fluorescently labeled ligands, 1023 M
in DMSO in microcentrifuge tubes, were diluted to 1025 M
in DMSO. Serial dilutions of the fluorescently labeled li-
gands in the range of 0.25 3 1026 M to 1.5 3 1026 M in
HSB/BSA were made in the spectrofluorometer cuvettes.
The final concentration of the labeled ligand solutions
contained 2.5–15% DMSO, which aided in the solubiliza-
tion of the ligand; however, DMSO did not interfere with
the absorbance and fluorescence measurements.1 The
concentrations of the fluorescein-labeled ligand were ver-
ified by absorbance measurements at 495 nm assuming an
extinction coefficient of 8.1 3 1024 for fluorescein-la-
beled peptide (16). The concentrations of the fluorescein-
labeled ligands calculated from absorbance measurements
corresponded to the concentrations based on the mass of
ligand used for the dilutions. Hence for the nonfluorescein
labeled ligands, the concentrations based on the mass of
the ligand used were assumed to be correct.
Spectrofluorometric determination of quenching
or enhancement of bound ligand fluorescence. The
number of bound ligand molecules per fluorescein equiv-
alent, Q, is crucial to quantifying kinetic binding data and
is equal to the product of two ratios that can be deter-
mined independently:
Q 5 F 3 Ib/If (1)
where F is the number of free ligands per fluorescein
equivalent (described above) and Ib/If is the ratio of fluo-
rescence of bound ligand to free ligand (4). The fluores-
cence of a ligand can be enhanced or quenched upon
binding to a receptor, and thus the value of Ib/If can be
greater or less than one. Because antibodies that suffi-
ciently quench the fluorescence of ligands labeled with
Bodipy and tetramethylrhodamine were unavailable, the
ratio of fluorescence of bound to free ligand, Ib/If, could
not be quantitatively measured as has been done previ-
ously for fluorescein-labeled ligands (4). Quenching or
enhancement of the fluorescently labeled ligand caused
by interactions with the receptor was qualitatively evalu-
ated by monitoring ligand binding on a spectrofluorom-
eter. In stirred square cuvettes, the cellular background
fluorescence of 1.5 ml of neutrophils at 107/ml in HSB/
BSA was monitored for 20 s before a fluorescent ligand
was added through a Hamilton syringe for a final concen-
1Varying the volume percentage of DMSO did not alter the fluorescence
of free fluorescein; hence DMSO did not effectively alter the fluorescent
moiety or solvent to effect the fluorescence of free fluorescein. In addi-
tion, the fluorescence of each fluorescein labeled ligand was the same
when the volume percentage of DMSO was held constant at 10% as
compared with when DMSO concentration varied from 2.5 to 15% (data
not shown).
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tration of 1 nM CHO-NLFFK-FL, 3 nM CHO-NLFNYK-
Bodipy, and 5 nM CHO-NLFNYK-TMR. Ligands were ei-
ther allowed to bind freely to the cell or blocked from
binding by the presence of the N-formyl peptide receptor
antagonist, t-Boc. t-Boc at 20 mM was allowed to prebind
for about 1 min prior to the addition of the fluorescently
labeled ligand.
The ligand concentrations utilized for these experi-
ments were chosen to maximize the ratio of bound to free
ligand with three experimental constraints in mind. First,
a minimum of 1 nM ligand was required for its fluores-
cence to be reliably measured. Second, the maximum
receptor concentration was limited by light scattering
effects that became evident at high cell concentrations. A
cell concentration of 107 cells/ml was the optimal con-
centration that would avoid these effects. Third, it was
desirable to have a ligand concentration larger than the
estimated equilibrium binding constant so that as many
receptors as possible were bound, but low enough so
significant free ligand depletion occurred.
Determination of Q with equilibrium binding
analysis and flow cytometry. An alternative method
for evaluating the calibration number Q (number of bound
ligand molecules per fluorescein equivalent) relied on
flow cytometric equilibrium binding data. These relative
measurements can be converted to specific numbers of
bound fluorescent ligand per cell (B) with the use of bead
standards by;
B 5 M 3 E 3 Q (2)
where M represents the flow cytometric measurement of
mean channel per cell and E is the number of fluorescein
equivalents per channel as calibrated by fluorescein-la-
beled bead standards. The quantum yield ratio (F from Eqn
1) for a well-characterized ligand that is not quenched
upon binding, CHO-NLFNYK-FL, was used as a reference
for evaluating the number of surface N-formyl peptide
receptors, which were assumed constant for a particular
cell preparation (4,20). The calibration values, Q, of the
other fluorescently labeled ligands were then calculated.
From these equilibrium-binding experiments, the equilib-
rium dissociation constants for the ligands were also eval-
uated. Predicted values of ligand quenching calculated
with the use of Eqn 1 and F and Q values were compared
qualitatively with spectrofluorometric quenching data.
The total number of N-formyl peptide receptors on the
cell membrane was found using a 4°C equilibrium-binding
assay described by Sklar and Finney (21). At 4°C receptor
upregulation, internalization and recycling is minimized
(3,8), and thus the total number of surface receptors can
be assumed constant. In brief, a saturable binding curve
was created by allowing various concentrations of a fluo-
rescently labeled ligand to bind to cells for at least 1 h at
4°C in the dark. All concentrations were done in dupli-
cate, and the specific concentrations were chosen in or-
der to obtain binding data above and below the Kd. To
account for nonspecific binding of the fluorescent ligand,
some cells were blocked with a high concentration of an
unlabeled ligand (1025 M CHO-MLF) before the fluores-
cently labeled ligand was added. After at least 1 h of
incubation, cells at 106/ml in HSB plus 1.5 mM Ca21 were
analyzed on a flow cytometer. The flow cytometer (Bec-
ton-Dickinson FACScan, San Jose, CA) was equipped with
an argon laser with 488 nm excitation wavelength and
two emission detectors: FL1, with a bandpass filter cen-
tered at 530 nm 6 30 nm, and FL2, with a bandpass filter
centered at 585 nm 6 42 nm. For all measurements the
compensation was set at zero. Incubation times longer
than 1 h gave no significant difference in Kd or total
number of surface receptors. The neutrophil population
was gated based on the forward and side scatter light and
the mean fluorescence intensity for each ligand concen-
tration was calculated using CellQuest software (Becton-
Dickinson, San Jose, CA).
Ligand fluorescence was calibrated daily to standard
beads (Quantum 24, Flow Cytometry Standards Corp.,
Puerto Rico). These standard beads were labeled with
fluorescein isothiocyanate (FITC) and the molecules of
equivalent soluble fluorochrome (MESF) per bead, listed
by the manufacturer, ranged from 3,000 to 65,000 MESF
per bead. The reported fluorescein equivalents per stan-
dard bead were verified by comparison to standard fluo-
rescein dilutions.
After subtraction of nonspecific binding from total bind-
ing, the concentrations of free ligands and specific recep-
tor-ligand complexes were determined. The total number
of surface N-formyl peptide receptors, Rtot, and the appar-
ent equilibrium dissociation constant, Kdapp, were evalu-
ated by minimizing the squared residual of the data points





where Rtot is the total number of surface receptors, [L] is
the free ligand concentration and [RL] is the bound recep-
tor concentration.
The calibration value Q for one fluorescently labeled
ligand (CHO-NLFNYK-FL) was taken from the previously
described spectrofluorometric calibration method. This
value was used together with the standard beads in order
to convert the mean fluorescence emitted to the number
of bound ligands (Eqn 1). The Rtot for that particular
experiment and Kdapp for the reference ligand were cal-
culated from fitting the bound ligand data to the one-site
model (Eqn 3). Once Rtot was established for that partic-
ular experiment, this value was kept constant while the
calibration number Q and Kdapp were allowed to change
when the equilibrium binding data for the other ligands
were fitted to the one-site model. These equilibrium bind-
ing data of the reference ligand and the other test ligands
were collected on the same day and with the same blood
donor so that donor variability in the total number of
surface receptors was not a factor. This analysis assumed
that the reference ligand and the other ligands bound to
the same site on the receptor. This was the case for
N-formyl peptide ligands binding to the N-formyl peptide
receptor as shown by competitive binding studies (7,9).
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The same equilibrium binding protocol was utilized to
evaluate total number of surface receptors (Rs) and equi-
librium binding constant for labeled ligand (Kdapp1) for
comparison with the competitive equilibrium binding
protocol.
Validation of Competitive Binding Protocols
Choice of ligands for competitive binding proto-
col. When excited at a wavelength of 490 nm, CHO-
NLFNYK-FL emits primarily at 520 nm while CHO-
NLFNYK-TMR emission is detectable around 580 nm, as
shown in Figure 1A. These emission wavelengths corre-
spond with the emission wavelengths of FL1 and FL2
channels on the flow cytometer and therefore direct mea-
surement of ligand binding was made using FL1 for CHO-
NLFNYK-FL and FL2 for CHO-NLFNYK-TMR. Note that the
broad spectrum for fluorescein was detectable at the
higher wavelength (580 nm) and thus fluorescein-labeled
standardized beads were also used for calibrating the FL2
signal. When equivalent concentrations of the two ligands
were excited at a wavelength of 490 nm, the peak emis-
sion of the CHO-NLFNYK-TMR was approximately an or-
der of magnitude less than that of the CHO-NLFNYK-FL
(Fig. 1A), although this was still sufficiently intense to
measure CHO-NLFNYK-TMR binding on FL2. The excita-
tion spectrum for CHO-NLFNYK-FL peaks around 490 nm
when emission is monitored at 530 nm, whereas the
excitation spectrum peaks around 550 nm for CHO-
NLFNYK-TMR when emission is monitored at 580 nm
(Fig. 1B and C). In other words, although the detector
filters of the particular flow cytometer utilized in this
study was not optimal for the tetramethylrhodamine la-
beled ligand, the emission was detectable compared to
background cellular fluorescence (see Fig. 2).
Equilibrium binding assay for labeled ligands.
Equilibrium binding for labeled ligands was performed as
described above for the determination of Q.
Kinetic binding assays for labeled ligands. For
labeled ligands an association protocol (protocol A) and
dissociation protocol (protocol B) were used and classi-
fied as “direct” kinetic binding measurements (8). Binding
of CHO-NLFNYK-FL or CHO-NLFNYK-TMR was monitored
on the flow cytometric detector centered at 530 nm (FL1)
or 585 nm (FL2), respectively. The temperature was main-
tained at 4°C throughout the assay by keeping the cell
samples in an ice-filled insulated beaker.
For protocol A, the autofluorescence of the unstimu-
lated cells at 106 cells/ml in HSB plus Ca12 was obtained
FIG. 1. Excitation and Emission spectra of CHO-NLFNYK-FL and CHO-
NLFNYK-TMR. (A) Emission spectra monitored with 490 nm excitation
on spectrofluorometer (SLM-Aminco 8100, Urbana, IL) from 100 nM
ligand concentration in HSB with 1 mg/ml BSA. Excitation spectra mon-
itored at 530 nm (B) and 580 nm (C). Specific emission or excitation
shown in the figure was equal to the measured fluorescence minus the
fluorescence of the carrier.
FIG. 2. Flow cytometric histrograms of beads and equilibrium binding
samples. Equilibrium binding samples were prepared as described in
Methods, and fluorescence was measured on the flow cytometer. Repre-
sentative histograms at FL1, 530 nm emission, of the standard calibration
FITC-labeled beads (A) and equilibrium binding of fluorescently labeled
ligand CHO-NLFNYK-FL (B). Representative histograms at FL2, 585 nm
emission, of the standard FITC-labeled calibration beads (C) and equilib-
rium binding of CHO-NLFNYK-TMR (D).
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for about 7 s. At 10 s the fluorescently labeled ligand was
added to the cell solution, and after quick mixing the tube
was immediately returned to the flow cytometer for col-
lection of data up to 3 min. It was crucial to minimize the
time off-line after addition of the ligand, in our case ap-
proximately 3 s. The concentration of the ligand used was
within an order of magnitude of Kdapp, as calculated from
equilibrium binding data. Ligand and cell concentrations
were chosen so that the free ligand concentration was not
appreciably depleted by ligand binding (2) and the back-
ground fluorescence from the free ligand was minimized.
Ligand concentrations of 3 nM and 6 nM for CHO-
NLFNYK-FL and 15 nM and 30 nM for CHO-NLFNYK-TMR
were used. Nonspecific binding was evaluated with cells
preincubated with 3 3 10-5 M CHO-MLF before the addi-
tion of the labeled ligand.
For protocol B, neutrophils at 106 cells/ml in HSB plus
Ca12 were incubated with labeled ligands. At 90 s or 2 h,
the binding of the labeled ligand was stopped by a rapid
addition of an excess amount of a ligand blocker and the
cell sample was quickly returned to the flow cytometer.
The blocker CHO-MLF was added at a concentration at
least a thousand fold higher than that of the labeled ligand,
e.g., 3 3 1025 M. The total time of data collection was 3
min. Dissociation was initiated after 90 s or 2 h of binding
in order to capture different receptor affinity states.
Equilibrium binding assay for unlabeled ligand.
As discussed and shown in Figure 1B, with 488 nm exci-
tation and 530 nm emission (FL1) CHO-NLFNYK-FL ap-
pears as a labeled ligand and CHO-NLFNYK-TMR appears
as an unlabeled ligand. Hence for the remaining discussion
of the competitive binding protocols, CHO-NLFNYK-FL is
referred to as the labeled ligand and CHO-NLFNYK-TMR is
referred to as the unlabeled ligand. The equilibrium bind-
ing constant, Kdappu, for the unlabeled ligand was deter-
mined by competitive equilibrium binding (6,8). Mixtures
of constant concentrations of the labeled ligand together
with variable concentrations of the unlabeled ligand were
allowed to bind to cells at 106/ml of HSB plus Ca21 for at
least 2 h at 4°C in the dark. Longer incubation times did
not yield significantly different equilibrium dissociation
constant estimates, and at least a 2-h incubation was de-
termined sufficient for the ligand binding to reach equi-
librium. Nonspecific binding was evaluated with cells pre-
incubated with 3 3 1025 M CHO-MLF before the mixture
of labeled and unlabeled ligand was added. After equilib-
rium was reached the amount of bound labeled ligand was
monitored on a flow cytometer and the specific bound
data was fit to a single site binding model, where the
labeled and unlabeled ligands were assumed to compete
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where [U] is the concentration of the unlabeled ligand and
Kdappu the equilibrium dissociation constant of the unla-
beled ligand. The equilibrium dissociation constant for the
labeled ligand, Kdapp1, was held constant at the value
found in the previously described equilibrium binding
assay.
Kinetic binding assays for unlabeled ligands. The
binding of unlabeled ligand was evaluated by competitive
binding of labeled and unlabeled ligand (8). Data were
collected with the flow cytometric detector centered at
530 nm, and thus the “labeled” ligand was CHO-
NLFNYK-FL and the “unlabeled” ligand was CHO-
NLFNYK-TMR. The analogous measurements with the
flow cytometric detector centered at 585 nm were not
feasible because the broad spectrum of fluorescein was
detectable at 585 nm, and much more intense than the
tetramethylrhodamine emission. This low tetramethylrho-
damine emission was because tetramethylrhodamine ab-
sorbance at 488 nm is about 5% that of absorbance at its
maximum. Attempts to compensate for fluorescein fluo-
rescence into the 585 nm channel resulted in unreliable
data because of high background signal. Therefore com-
petition by CHO-NLFNYK-FL while measuring CHO-
NLFNYK-TMR was not evaluated. As with the direct ki-
netic binding assays, the competitive binding protocols
(indirect kinetic binding assays) included an association
protocol and a displacement protocol, and the tempera-
ture of 4°C was maintained through out the assay.
The competitive association protocol (protocol C) was
the same as protocol A except that labeled and unlabeled
ligands were added simultaneously. Concentrations of the
unlabeled ligand and the labeled ligand were varied in
order to optimize the measurements of labeled ligand
binding and better distinguish the effect of the unlabeled
ligand binding. With too much of the labeled ligand
present, the effect of the competing unlabeled ligand was
not detectable. Similarily, too much unlabeled ligand
blocked the labeled ligand from binding, and the fluores-
cence measured was not distinguishable from nonspecific
binding. Mixtures of 3 nM/15 nM, 6 nM/15 nM, and 6
nM/30 nM of CHO-NLFNYK-FL/CHO-NLFNYK-TMR, were
utilized.
For the competitive displacement protocol (protocol
D), unlabeled ligand (CHO-NLFNYK-TMR) was added ini-
tially and then displacement of unlabeled ligand was ini-
tiated by addition of labeled ligand (CHO-NLFNYK-FL).
Hence there was an increase in fluorescence after dis-
placement was initiated. For protocol D, cells at 106
cells/ml of HSB plus Ca12 were allowed to bind with the
unlabeled ligand until binding was interrupted by the
rapid addition of the labeled ligand. For short-time dis-
placement experiments, the unlabeled ligand was allowed
to bind for 15–90 s prior to the addition of the labeled
ligand, and the displacement of unlabeled ligand was
monitored for approximately 3 min. Ligand concentra-
tions used were 3 nM/15 nM and 6 nM/30 nM of CHO-
NLFNYK-FL/CHO-NLFNYK-TMR. For long-time displace-
ment experiments, the unlabeled ligand was allowed to
bind for at least 15 min in order to convert the majority of
the surface receptors to the high-affinity state. At this
high-affinity state, the displacement of the unlabeled li-
gand by the labeled ligand was slow, and therefore the
displacement of unlabeled ligand was monitored in incre-
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ments of 2 min, for over 20 min. For the long-time dis-
placement, the concentrations of the unlabeled and la-
beled ligands were optimized to quickly convert the
receptors to the high-affinity state and to minimize the
rebinding of unlabeled ligand after the addition of labeled
ligand, hence the ligand concentrations were different
from protocol C. The labeled ligand concentration was
kept at least an order of magnitude larger than the con-
centration of the unlabeled ligand; 15 nM CHO-NLFNYK-
TMR and 250 nM CHO-NLFNYK-FL were utilized. Another
concern was the evaluation of the nonspecific binding
caused by the high-labeled ligand concentration. There-
fore a larger concentration of blocker was used in proto-
col D compared to all the other protocols. For the non-
specific binding, the cells were preincubated with 0.1 mM
of the blocker, CHO-MLF, prior to the addition of the
unlabeled and labeled ligand.
Analysis of kinetic binding data. Kinetic binding
data were collected on the flow cytometer using Cell
Quest Software (Becton Dickinson), which was used to
gate the neutrophil population based on the forward and
side scatter. The gated kinetic data was saved in Flow
Cytometry Standard format (FCS) and moved to a UNIX
platform, where the data was converted to ASCII. The data
parameters, forward scatter, side scatter, and fluores-
cence, were averaged over each 200-ms time interval and
the fluorescence values were converted to number of
bound receptors by a specific ligand calibration value;
1.02 for CHO-NLFNYK-FL and 2.22 for CHO-NLFNYK-TMR
(see previous sections). Nonspecific binding was de-
scribed by a linear function and subtracted from the raw
data yielding data of bound ligand per cell versus time.
The total number of surface receptors, Rtot, and the equi-
librium dissociation constant, Kdapp, were obtained from
equilibrium binding analysis. Because of the irreversible
conversion of the low-affinity state to the high-affinity
state, Kdapp was assumed equal to the equilibrium disso-
ciation constant, Kdx, for the high-affinity state of the
receptor (Kdx 5 kr2/kf2) (8).
To determine the reaction rate constants for the labeled
ligand, 2-h dissociation data from protocol B were ana-
lyzed first. After 2 h of binding, essentially all surface
receptors were irreversibly converted to the high-affinity
state. Hence the binding model could be reduced to a
one-site binding model (8). The analytical solution for a
one-site model was used to fit these data with the assump-
tion that the free (unbound) labeled ligand concentration
was zero after the addition of the blocker, CHO-MLF,
which was present in great excess compared to the la-
beled ligand. The following equation was used in Mi-
crosoft Excel with the method of least squares to find the
dissociation rate constant from the high-affinity receptor,
LRx~t! 5 LRx,0exp~2kr2t! (5)
The value for the initial number of receptor-ligand com-
plexes, LRx,o, was obtained from averaging the number of
high-affinity complexes from the first 10 s of data collec-
tion (before CHO-MLF is added). The value for kf2 was
calculated from duplicates with the constraint of Kdx, and
the average value of both kf2 and kr2 were held constant
throughout the data analysis for that particular day.
Association data (protocol A) and 90-s dissociation data
(protocol B) for labeled ligand were analyzed using equa-
tions describing the full two-site binding model (see Ap-
pendix) and the program Scientist (Micromath, Salt Lake
City, UT), which utilized Powell’s algorithm, a hybrid
between the Gauss-Newton and steepest descent meth-
ods, to fit the data. The data were fit to minimize the sum
of residuals with the assumption of constant absolute
error and equal weight to all data points. Association data
were fit by constraining the values of kf2 and kr2 as de-
scribed above and allowing the values of kf, kr, and kx to
vary. Initial estimates were taken from Hoffman et al. (8).
The criteria for further use of the evaluated rate constants
was that the standard deviations of the fit values for the
rate constants were at least an order of magnitude less
than the rate constants themselves. The 90-s dissociation
data from protocol B were analyzed with the assumption
that the apparent labeled ligand concentration was zero
after the addition of blocker. The blocker, CHO-MLF, was
added at a concentration at least a thousand-fold greater
than the labeled ligand concentration, which greatly re-
duced the probability of labeled ligand rebinding. Again,
the parameters kr2 and kf2 were constrained as described
above, while kf, kr, and kx were allowed to vary. The
values from association fits were used as initial guesses for
their values. Analyses of both association and 90-s disso-
ciation data yielded similar rate constants; however, 90-s
dissociation data gave more confidence in kx compared to
the association data. The confidence was evaluated by the
ratio of the rate constant estimate to standard deviation
determined by Scientist for a particular fit. The reported
average value for kx includes values evaluated from both
association and 90-s dissociation data.
Competitive binding data (both labeled and unlabeled
ligands) were analyzed in the following way. Equilibrium
binding data were analyzed using Eqn 4 to give Kdappu,
assumed to be the dissociation constant for the high-
affinity receptor state (Kdu 5 kr2u/kf2u) for CHO-NLFNYK-
TMR. The value of Rtot calculated from the competitive
equilibrium data was consistent with the value calculated
from direct equilibrium data. Kinetic binding data from
protocols C and D were analyzed using Micromath Scien-
tist and the equations in the Appendix to obtain rate
constants for the unlabeled ligand. Rate constants for the
labeled ligand (CHO-NLFNYK-FL) were held constant at
the values determined by direct measurements described
above. To make comparisons of the reaction rate con-
stants evaluated by the different methods, direct and com-
petitive, it was necessary to carry out both (i.e., protocols
A–D) on the same day (same donor).
Analysis of long-time displacement data (protocol D)
was done assuming that prior to the addition of labeled
ligand, all receptors were in the high-affinity state and
occupied by unlabeled ligand. This assumption was rea-
sonable based on the time scale of data collection and
estimated values of the initial binding rate constants, kf, kr,
and kx. Long-time displacement data were fit to two single-
site binding models describing the binding of the labeled
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and the unlabeled ligand to the high-affinity state of the
receptor. The value of the reaction rate constant of kr2u
was evaluated using Scientist while holding the rate con-
stants for the labeled ligand, kr2 and kf2, constant and
constraining kf2u by Kdxu, as evaluated by the competitive
equilibrium binding. After the duplicates of the long-time
displacement data were analyzed, the reaction rate con-
stants of kr2u and kf2u were averaged and held constant for
that particular experiment.
Competitive association and short-time displacement
data from protocols C and D were fit to the entire two-site
binding model for both the labeled and the unlabeled
ligand by Micromath Scientist. The data were analyzed
under the constraints of reaction rate constants for the
labeled ligand calculated earlier and the high-affinity reac-
tion rate constants, kf2u and kr2u, from long-time displace-
ment data, while kfu, kru, and kxu were allowed to vary.
The assessment of a successful fit was the same as for the
direct binding analysis.
The various reaction rate constants calculated from the
direct and competitive binding assays were averaged per
day (per donor), and the standard deviation caused by
donor was also evaluated. The final reported values for the
reaction rate constants are the averages of the daily aver-
ages, and the standard errors of the mean are based on the
daily averages. The statistical analysis for comparison of
the reaction rate constants for CHO-NLFNYK-TMR calcu-
lated from direct measurements and from the competitive
binding protocol are based on paired sample t test, where
the daily values were paired and compared. The same
method was utilized to compare the reaction rate con-
stants calculated from direct measurements for CHO-
NLFNYK-FL and CHO-NLFNYK-TMR.
RESULTS
In this paper, we have validated the utility of competi-
tive binding protocols for evaluating the kinetic binding
dynamic of unlabeled ligands. Additionally, we calibrate
the relative intensity of flow cytometric fluorescence mea-
surements to numbers of bound ligands, including the
potential quenching or enhancement of fluorescence
caused by receptor-ligand interaction, for several new
N-formyl peptide ligands.
Spectrofluorometric Determination of the
Quantum Yield Ratio, F
The spectrofluorometric calibration method described
by Fay et al. (4) was used to calibrate serial dilutions of the
labeled ligands CHO-MLFK-FL, CHO-NLFFK-FL, N- CHO-
MLFFK-FL, CHO-NLFNYK-FL, CHO-NLFNYK-Bodipy, and
CHO-NLFNYK-TMR to standard free fluorescein solutions
and to calculate F, the ratio of fluorescence of fluorescein
to fluorescent ligand. The ratio of the emission readings of
the fluorescently labeled ligand to the free fluorescein was
calculated and resulted in the quantum yield ratio F, as
summarized in Table 1.
Flow Cytometric Determination of the
Calibration Number Q
Equilibrium binding studies were used to determine the
value of the calibration number Q for the different ligands
relative to CHO-NLFNYK-FL. Figure 2 depicts representa-
tive histograms of equilibrium binding data for fluores-
cently labeled ligands at an emission wavelength of 530
nm and 585 nm. Different concentration ranges were used
for the various ligands based on their affinities for the
N-formyl peptide receptor. Note that the fluorescein-la-
beled calibration beads had significant emission at 585 nm
and therefore could be used to calculate the calibration
number for CHO-NLFNYK-TMR. Furthermore, even
though the excitation wavelength (488 nm) was not op-
timal for tetramethylrhodamine (see Fig. 1), the ligand
emission was distinguishable from the cellular back-
ground fluorescence. Mean channel numbers for each
histogram were calculated and equilibrium-binding curves
(see Fig. 3) were obtained as described in Methods. The
Table 1
Summary of Calibration Values Evaluated Spectrofluorometrically, F, and Flow Cytometrically, Q,






CHO-NLFNYK-FL 1.02 6 0.03 (3) 1.02 6 0.00 (39) 1.00 1.26 6 0.29 1.00
CHO-NLFNYK-Bodipy 2.60 6 0.25 (4) 1.43 6 0.07 (11) 0.55 6 0.11
CHO-NLFNYK-TMR 2.31 6 0.32 (3) 2.22 6 0.19 (30) 0.96 6 0.31
CHO-MLFFK-FL 2.13 6 0.04 (2) 0.83 6 0.07 (5) 0.39 6 0.06 1.39 6 0.51 0.54 6 0.04
CHO-NLFFK-FL 2.14 6 0.08 (2) 0.79 6 0.06 (5) 0.37 6 0.06
CHO-MLFK-FL 0.92 6 0.04 (4) 0.92 6 0.06 (10) 0.99 6 0.15 1.12 6 0.13 0.72 6 0.05
aMean 6 SEM, n in parentheses.
bCalculated from F and Q using Eqn 1.
cFrom Fay et al. (4) at 520 nm emission.
dQuantum yield ratio F calculated as described by Fay et al. (4) with the following arrangement: excitation
monochromator set at 490 nm with slit widths of 2 nm and the excitation light filtered through a 10 nm bandpass filter
centered at 490 nm (Corion, Holliston, MA). For fluorescein-labeled ligands, emission monochromator was set at 530 nm
with slit widths of 1 nm, emitted light was additionally filtered with a 10 nm bandpass filter centered at 530 nm (Ealing,
Holliston, MA), and an emission cut-off filter 3–70 (Kopp Glass, Inc., Pittsburgh, PA) was used to further reduce
detection of scattered excitation light. For the tetramethylrhodamine labeled ligand, the emission monochromator was
set at 580 nm with slit widths of 1 nm and emission light was further filtered using a 10 nm bandpass filter centered at
580 nm (Ealing, Holliston, MA). Emission was measured as 10 s of integrated photons.
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value Q was determined for test ligands relative to CHO-
NLFNYK-FL with the assumption of constant Rtot as de-
scribed in Methods. These calculated Q numbers are sum-
marized in Table 1.
Evaluation of Quenching Ratio, Ib/If
Predicted values of Ib/If, the ratio of fluorescence inten-
sity of bound to free ligand, were calculated from the Q
values obtained flow cytometrically and the F values de-
termined spectrofluorometrically (Table 1). For three of
the ligands, the ratio Ib/If has been reported utilizing the
antibody-quenching approach of Fay et al. (4), although
the emission wavelength for their studies differed slightly
from ours (520 nm versus 530 nm). Our predicted Ib/If
ratios agree well with these previously published values.
The fluorescence intensity ratios of bound versus free
ligand could not be directly quantified for Bodipy and
TMR labeled ligands because of a lack of antibodies that
sufficiently quenched the fluorescence of these moieties.
However, Figure 4 displays representative data qualita-
tively showing the quenching (or lack thereof) for these
ligands for which Ib/If had not been previously reported.
Our predicted Ib/If ratios were in good agreement with
the qualitative measurements of quenching shown in Fig-
ure 4.
Equilibrium Binding Constants
The equilibrium binding experiments were also used to
obtain the apparent equilibrium dissociation constants,
Kdapp, for the ligands tested (Table 2). Although all of
these peptide ligands bound to the same site on the
N-formyl peptide receptor, there was a nearly two-order
of magnitude range in the Kdapp, from 0.06 nM to 2.55 nM.
Interestingly, the identity of the fluorescent tag influenced
FIG. 4. Qualitative assessment of quenching of ligand fluorescence
upon binding. Data was obtained spectrofluorometrically as described in
Methods using a cell concentration of 1 3 107 cells/ml for CHO-NLFNYK-
Bodipy (A), CHO-NLFNYK-TMR (B), and CHO-NLFFK-FL (C). Data was
collected in the presence (solid traces) and absence (dashed traces) of a
nonfluorescent receptor antagonist, t-Boc. Predicted values of normalized
fluorescence caused by ligand quenching, calculated from Kdapp and
predicted Ib/If with the assumption of 0.66 nM receptor concentration
(i.e., 40,000 receptors/cell), were 0.92, 0.99, and 0.61, respectively.
FIG. 3. Equilibrium binding curves. Representative equilibrium binding
curves of receptor-ligand complexes normalized to the experimental Rtot
versus the ligand concentration for CHO-NLFNYK-FL (A), CHO-NLFNYK-
Bodipy (B), CHO-MLFK-FL (C), CHO-NLFNYK-TMR (D), CHO-NLFFK-FL
(E), and CHO-MLFFK-FL (F). Data in panels A–D were collected on the
same day for which Rtot (determined with CHO-NLFNYK-FL) was 39,892
receptors/cell. Data in panels E and F were collected on a different day
with cells from a different donor; For this experiment Rtot (determined
with CHO-NLFNYK-FL) was 44,606.
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the binding of the ligand to the receptor as seen by the
differences in Kdapp for the three ligands with the same
peptide sequence (CHO-NLFNYK-FL, CHO-NLFNYK-
Bodipy, and CHO-NLFNYK-TMR). The calculated Kdapp
values correlate well with previously published values of
equilibrium binding constants that are available for some
of the ligands tested.
Ligand-Dependent Binding Rate Constants via
Direct Binding Protocols
The binding and dissociation of two fluorescent ligands,
CHO-NLFNYK-FL and CHO-NLFNYK-TMR, were moni-
tored using flow cytometry (protocols A and B) with
emission wavelengths of 530 nm and 585 nm, respec-
tively. Data were fit to the two-site binding model to
obtain values of the rate constants kf, kr, kx, kf2, and kr2,
constraining the ratio kr2/kf2 to be equal to the value of
Kdapp calculated from equilibrium binding experiments.
Figure 5 depicts kinetic binding data collected via three
different direct measurements for CHO-NLFNYK-TMR.
The solid lines show the fit of the two site binding model
to these data. The reaction rate constants describing bind-
ing, kf, and dissociation, kr, of the low-affinity receptor/
ligand complex, and receptor affinity conversion, kx, were
calculated from association binding data and 90-s dissoci-
ation data, as significant numbers of the low-affinity recep-
tor/ligand complex are present for these experimental
time scales. The reaction rate constants governing the
lifetime of the high-affinity state, kf2 and kr2, were evalu-
ated from long-time, or 2-h, dissociation data, as significant
numbers of the high affinity receptor/ligand complex are
present at this experimental time scale. The same type of
data collection was carried on for CHO-NLFNYK-FL at a
different emission wavelength, 530 nm, as has been pre-
viously reported (8). The values of the reaction rate con-
stants calculated based on these direct measurements are
listed in Table 3.
The ligands CHO-NLFNYK-FL and CHO-NLFNYK-TMR
differ only in the fluorescent tag, and not in the peptide
sequence. Using a paired sample t test to compare the
values of the reaction rate constants calculated for each
day and for each ligand, all the reaction rate constants can
be shown to be statistically different except for the disso-
ciation rate constant, kr. Thus most of the reaction rate
constants describing the two site binding model of the
N-formyl peptide receptor are ligand dependent, even for
these two very similar ligands. It is not clear from the
present study whether the dissociation constant kr is en-
tirely ligand independent or simply more dependent upon
the peptide sequence than the fluorescent tag, although
an earlier study (22) using different ligands for the N-
formyl peptide receptor shows kr to be ligand dependent.
Ligand-Dependent Binding Rate Constants via
Competitive Binding Protocols
The binding of unlabeled ligand is indirectly measured
by the effect it has on the binding of the labeled ligand.
The tetramethylrhodamine labeled ligand, CHO-NLFNYK-
TMR, does not have significant emission at the lower
FIG. 5. Direct measurements of CHO-NLFNYK-TMR binding. Kinetic
binding data (dots) and model fit (line) for CHO-NLFNTNK-TMR binding
to the N-formyl peptide receptor collected via association protocol (A),
90-s dissociation protocol (B), and 2-h dissociation protocol (C) at 585
nm. These data were all taken on the same day (single donor).
Table 2





CHO-NLFNYK-FL 0.55 6 0.04 (39) 0.35 6 0.2b
CHO-NLFNYK-Bodipy 0.97 6 0.18 (11)
CHO-NLFNYK-TMR 2.55 6 0.25 (30)
CHO-MLFFK-FL 0.06 6 0.02 (5) 0.03c
CHO-NLFFK-FL 0.07 6 0.01 (5)
CHO-MLFK-FL 0.12 6 0.02 (10) 0.04c
aMean 6 SEM, n in parentheses.
bFrom Hoffman et al. in intact cells (8).
cFrom Fay et al. in permeabilized cells (24).
111VALIDATION OF COMPETITIVE BINDING PROTOCOLS
emission wavelength (530 nm) when excited at 488 nm; it
can be used as an unlabeled ligand when observing fluo-
rescent at the FL1 channel. Different concentration ratios
were tested given the constraints listed in Methods, and
the ratio of 6 nM/15 nM of CHO-NLFNYK-FL versus CHO-
NLFNYK-TMR yielded optimal results.
Competitive association binding of CHO-NLFNYK-FL
and CHO-NLFNYK-TMR (protocol C) is shown in Figure 6.
For comparison, binding of CHO-NLFNYK-FL alone is also
shown. When CHO-NLFNYK-FL fluorescence is monitored
in the presence of unlabeled ligand (CHO-NLFNYK-TMR),
less binding occurs than for CHO-NLFNYK-FL alone, con-
sistent with competition of the two ligands for the recep-
tor. This difference in binding was used to calculate the
reaction rate constants governing the formation of the
low-affinity receptor-ligand complex for the unlabeled li-
gand CHO-NLFNYK-TMR.
Displacement of unlabeled ligand by the labeled ligand
(protocol D) was monitored at different timescales to
capture the different dynamic states of the receptor.
Short-time displacement data (Fig. 7A) were collected
with the same ratio of ligand concentrations as in the
FIG. 7. Displacement data at variable timescales. Data of prebound
CHO-NLFNYK-TMR being displaced by CHO-NLFNYK-FL (dots) collected
at 530 nm under various timescales; short-timescale (A) where 15 nM of
CHO-NLFNYK-TMR was incubated with cells at 106/ml for 15, 30, 60, or
90 s prior to the addition of 6 nM CHO-NLFNYK-FL and long-timescales
(B) where 30 nM of CHO-NLFNYK-TMR was incubated with cells for at
least 15 min prior to the addition of 250 nM of CHO-NLFNYK-FL. The
short-time displacement data were fit with a two-site binding model (line),
and the long-time displacement data were fit with single-site binding
model (line) describing the high-affinity state of the N-formyl peptide
receptor.
Table 3









21 s21)a 7.4 6 0.5 3 106 (16)e 3.1 6 0.2 3 106 (16) 3.37 6 0.3 3 106 (7)f
kr (s
21)a 1.14 6 0.06 3 1021 (16) 1.23 6 0.05 3 1021 (16) 1.40 6 0.2 3 1021 (7)f
kx (s
21)b 2.36 6 0.1 3 1022 (16)e 1.45 6 0.09 3 1022 (16) 1.91 6 0.07 3 1022 (7)f
kr2 (s
21)c 9.33 6 1.0 3 1024 (16)e 1.31 6 0.08 3 1023 (16) 0.31 6 0.07 3 1023 (4)
kf2 (M21 s21)c 2.10 6 0.2 3 106 (16)e 6.17 6 0.5 3 105 (16) 0.89 6 4 3 105 (4)
aBinding rate constants calculated from association and 90-s dissociation protocols for direct methods and
from competitive association protocol.
bBinding rate constants calculated from direct association and 90-s dissociation protocol or short-time
displacement protocol for competitive binding.
cBinding rate constants evaluated with the constraint on kf 2 from equilibrium binding constraint, Kdapp
5 kr2/kf 2, from 2-h dissociation for direct measurements or from long-time displacement protocols for
competitive binding.
dMean 6 SEM, n in parentheses.
eStatistically different from values determined by direct measurements for CHO-NLFNYK-TMR.
fStatistically the same as the values determined by direct measurements for CHO-NLFNYK-TMR.
FIG. 6. Competitive association binding. Kinetic binding data (dots) and
model fits of association kinetic binding of 6 nM CHO-NLFNYK-FL (trace
A) and competitive association binding of a mixture of 6 nM CHO-
NLFNYK-FL and 15 nM CHO-NLFNYK-TMR (trace B) measured at an
emission wavelength of 530 nm.
112 WALLER ET AL.
competitive association data. The unlabeled ligand CHO-
NLFNYK-TMR was allowed to bind for 15 s or up to 90 s
before addition of the labeled ligand CHO-NLFNYK-FL.
The initial receptor-ligand complex had a low affinity for
ligand and the dynamic existence of this low-affinity re-
ceptor state was evident in the short-time displacement
data. At earlier time points (i.e., 15 s), the labeled ligand
rapidly displaced the unlabeled ligand from the low-affin-
ity receptor, while at later time points (i.e., 90 s) more of
the receptors had converted into the high-affinity state
and the displacement of the unlabeled ligand was slower.
The long-time displacement data, shown in Figure 7B,
resulted in estimates for the dissociation reaction rate
constant from the high-affinity receptor state, kr2. This
method required extensive optimizations regarding the
ligand concentrations to utilize and when to initiate the
displacement, as described in Methods. The concentra-
tions of 30 nM CHO-NLFNYK-TMR and 250 nM of CHO-
NLFNYK-FL were utilized and the nonspecific binding was
blocked with 0.1 mM CHO-MLF. Furthermore, from the
estimates of the binding rate constants we verified that 30
nM CHO-NLFNYK-TMR binding for 15 min resulted in
over 90% conversion of the surface receptors to the high-
affinity state.
The reaction rate constants for CHO-NLFNYK-TMR cal-
culated from the competitive binding protocols are listed
in Table 3. Statistically, the binding rate constants describ-
ing the formation and lifetime of the low-affinity receptor
state, kf, kr, and kx, as calculated from competitive binding
protocols, were no different from the reaction rate con-
stants calculated from direct measurements, according to
a paired sample t-test analysis. However, reaction rate
constants describing the high-affinity receptor state, kr2
and kf2, were not statistically similar. These reaction rate
values were less than an order of magnitude different from
the values determined from direct binding measurements.
Thus we conclude that the competitive binding protocol
provided estimates of kf, kr, and kx that were identical to
those measured directly, and provided estimates of kr2 and
kf2 that were accurate to within an order of magnitude.
DISCUSSION
In this paper, we have extended the methods of Fay et
al. (4) for calibrating flow cytometric mean channel num-
bers to number of bound ligands to include the calibration
of ligands labeled with fluorophores other than fluores-
cein. The calibration parameter, Q, represents the number
of bound ligands per fluorescein equivalent and together
with fluorescein-labeled standardized beads allows con-
version of the relative flow cytometric intensity measure-
ments to bound ligand per cell. These calibration values
are essential for quantifying receptor-ligand interactions
and obtaining rate constants for receptor-ligand binding.
We utilized these values when evaluating the kinetic bind-
ing dynamics of two different fluorescently labeled ligands
for validating competitive binding protocols.
The calibration strategy employed was to establish a
calibration value by spectrofluorometric measurements
for one fluorescent ligand compared to a standard bead
fluorescence (fluorescein in this study). The calibration
parameters, Q, for the other ligands were easily calculated
based on flow cytometric equilibrium binding data. This
approach is generally applicable to other cell surface re-
ceptor systems with the restriction that all the fluores-
cently labeled ligands bind to the same receptor site with
known stoichiometry (one ligand to one receptor, in this
case).
The calibration studies also yielded equilibrium dissoci-
ation constants for a set of six ligands, all of which bind to
the N-formyl peptide receptor. Interestingly, these affini-
ties varied significantly for these peptides, and even varied
between identical peptides (NLFNYK) with different flu-
orescent tags (FL, Bodipy, TMR). Sklar et al. (20) have
reported that the fluorescein on CHO-NLFNYK-FL is not in
the binding pocket of the N-formyl peptide receptor, and
hence it was an unexpected result that the fluorescent tag,
which is outside of the binding pocket, would still influ-
ence the binding. This observation suggests that the fluo-
rescent moiety interacts with the receptor on regions
outside of the binding pocket.
Additionally, we have validated a set of competitive
binding protocols applicable for analyzing receptor-ligand
interactions described by a two site binding model. The
competitive binding protocols described yielded statisti-
cally similar reaction rate constants to those calculated
from direct measurements for the formation and lifetime
of the low-affinity receptor state (kf, kr, and kx). Because
the low-affinity form of the receptor is thought to be the
signaling state (22,23), the values of these rate constants
are most important and can be used to understand the role
that binding dynamics plays in cell activation. These com-
petitive binding protocols were able to estimate reaction
rate constants regulating the high-affinity receptor state
(kr2 and kf2) within an order of magnitude. The use of
competitive binding protocols will greatly expand the
number of ligands, including unlabeled and low-affinity
ligands, available for future quantitative studies.
Finally, although the studies presented here focused on
the neutrophil, these calibration methods and kinetic
binding measurement techniques are applicable to other
cellular receptor systems. We also speculate that our find-
ing of ligand-dependent receptor binding and processing
rate constants will be shown to be true for many other
receptor systems.
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APPENDIX
Model I describes the binding of a fluorescently labeled
ligand L. The binding of an unlabeled ligand U is described
by:








U 1 Rx (Model AI)
The apparent receptor-ligand complex number that is
measured by flow cytometry, [LR]app, is equal to:
@LR#app 5 @LRs# 1 @LRx# (A1)
The differential equations describing Models I and AI are
listed below. For analysis of only labeled ligand binding,
the concentration of the unlabeled ligand, [U], is equal to
zero.
d@LRs#/dt 5 kf @L#@Rs# 2 ~kr 1 kx!@LRs# (A2)
d@LRx#/dt 5 kx@LRs# 2 kr2@LRx# 1 kf @L#@Rx# (A3)
d@URs#/dt 5 kfu@U#@Rs# 2 ~kru 1 kxu!@URs# (A4)
d@URx#/dt 5 kxu@URs# 2 kr2u@URx# 1 kfu@U#@Rx# (A5)
d@Rx#/dt 5 kr2@LRx# 2 kf 2@L#@Rx#
1 kr2u@URx# 1 kf 2u@U#@Rx# (A6)
d@Rs#/dt 5 kr@LRs# 2 kf @L#@Rs#
2 kfu@U#@Rs# 1 kru@URs# (A7)
d@L#/dt 5 $2kf @L#@Rs# 1 kr@LRs# 1 kr2@LRx# 2 kf 2@L#@Rx#%
3 $n~ Av!21~V !21% (A8)
d@U#/dt 5 $2kfu@U#@Rs# 1 kru@URs#
1 kr2u@URx# 2 kf 2u@U#@Rx#}$n~ Av!
21~V !21% (A9)
V is the assay volume in liters, n is the number of cells in
the assay volume, and Av is Avogadro’s number.
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